X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (25146) 25146
Publication (3868) 3868
Book Review (298) 298
Book Chapter (150) 150
Conference Proceeding (30) 30
Dissertation (30) 30
Book / eBook (9) 9
Magazine Article (6) 6
Data Set (4) 4
Government Document (3) 3
Paper (2) 2
Streaming Video (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16117) 16117
humans (15298) 15298
cancer (7567) 7567
oncology (7466) 7466
animals (7340) 7340
apoptosis (6683) 6683
cell line, tumor (6258) 6258
cell biology (6134) 6134
cell cycle (5567) 5567
biochemistry & molecular biology (4553) 4553
immunotherapy (4147) 4147
mice (3987) 3987
apoptosis - drug effects (3905) 3905
phosphorylation (3858) 3858
female (3758) 3758
proteins (3635) 3635
dna damage (3600) 3600
cell cycle checkpoints - drug effects (3211) 3211
expression (3210) 3210
cell proliferation - drug effects (3049) 3049
tumors (2922) 2922
research (2820) 2820
article (2675) 2675
immune checkpoint (2578) 2578
checkpoint (2575) 2575
antineoplastic agents - pharmacology (2529) 2529
cell cycle proteins - metabolism (2521) 2521
male (2476) 2476
analysis (2421) 2421
chemotherapy (2419) 2419
activation (2384) 2384
signal transduction (2339) 2339
kinases (2296) 2296
gene expression (2175) 2175
cell proliferation (2138) 2138
mitosis (2092) 2092
care and treatment (1976) 1976
mutation (1954) 1954
protein-serine-threonine kinases - metabolism (1932) 1932
melanoma (1878) 1878
metastasis (1845) 1845
genetic aspects (1813) 1813
p53 (1773) 1773
cancer therapies (1743) 1743
dna repair (1723) 1723
genetics & heredity (1652) 1652
biology (1642) 1642
health aspects (1626) 1626
dna (1621) 1621
multidisciplinary sciences (1617) 1617
dna-damage (1591) 1591
immunology (1587) 1587
cells (1558) 1558
pharmacology & pharmacy (1553) 1553
tumor suppressor protein p53 - metabolism (1553) 1553
signal transduction - drug effects (1518) 1518
inhibition (1514) 1514
research article (1495) 1495
cell cycle proteins - genetics (1475) 1475
cell cycle checkpoints (1464) 1464
hela cells (1433) 1433
cytotoxicity (1429) 1429
nivolumab (1428) 1428
deoxyribonucleic acid--dna (1413) 1413
rna interference (1385) 1385
cell line (1372) 1372
protein (1367) 1367
cell survival - drug effects (1348) 1348
growth (1348) 1348
lung cancer (1347) 1347
cell death (1340) 1340
therapy (1331) 1331
proliferation (1326) 1326
lymphocytes (1324) 1324
physiological aspects (1284) 1284
protein kinases - metabolism (1281) 1281
patients (1251) 1251
medicine (1246) 1246
checkpoint kinase 1 (1245) 1245
breast cancer (1242) 1242
flow cytometry (1224) 1224
saccharomyces-cerevisiae (1200) 1200
middle aged (1156) 1156
in-vitro (1144) 1144
cell growth (1123) 1123
cell-cycle (1123) 1123
dose-response relationship, drug (1121) 1121
xenograft model antitumor assays (1117) 1117
survival (1104) 1104
gene expression regulation, neoplastic (1096) 1096
immune checkpoint inhibitors (1091) 1091
dna replication (1087) 1087
mice, nude (1087) 1087
medicine, research & experimental (1081) 1081
lymphocytes t (1064) 1064
review (1035) 1035
protein binding (1032) 1032
ipilimumab (1024) 1024
inhibitors (1020) 1020
protein-serine-threonine kinases - genetics (1019) 1019
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (24900) 24900
German (113) 113
French (93) 93
Chinese (69) 69
Japanese (29) 29
Russian (14) 14
Spanish (13) 13
Korean (10) 10
Czech (8) 8
Polish (4) 4
Catalan (1) 1
Dutch (1) 1
Hungarian (1) 1
Italian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Cancer, ISSN 1474-175X, 01/2017, Volume 17, Issue 2, pp. 93 - 115
Journal Article
International Journal of Cancer, ISSN 0020-7136, 07/2018, Volume 143, Issue 1, pp. 45 - 51
Journal Article
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2016, Volume 44, pp. 51 - 60
Highlights • Role of immune checkpoint inhibition in the management of key malignancies. • Description of rates of immune-related adverse events and timing of... 
Hematology, Oncology and Palliative Medicine | Pembrolizumab | Immune-related adverse events | Renal cancer | Ipilimumab | Nivolumab | Lung cancer | Melanoma | Immune-checkpoint inhibitors | OPEN-LABEL | SINGLE-ARM | ANTI-CTLA-4 ANTIBODY | METASTATIC MELANOMA | ONCOLOGY | ADVANCED MELANOMA | LONG-TERM SAFETY | MALIGNANT MESOTHELIOMA | ENTERIC NEUROPATHY | ADVERSE EVENTS | IPILIMUMAB RETREATMENT | Lung Neoplasms - drug therapy | Skin Neoplasms - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Adrenal Cortex Hormones - therapeutic use | Diarrhea - chemically induced | Infliximab - therapeutic use | Drug Eruptions - drug therapy | Antineoplastic Agents - adverse effects | Colitis - chemically induced | Antilymphocyte Serum - therapeutic use | Colitis - drug therapy | Carcinoma, Renal Cell - drug therapy | Chemical and Drug Induced Liver Injury - etiology | Pituitary Diseases - chemically induced | Pituitary Diseases - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Neoplasms - drug therapy | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Melanoma - drug therapy | Chemical and Drug Induced Liver Injury - drug therapy | Diarrhea - drug therapy | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Thyroiditis - drug therapy | Thyroiditis - chemically induced | Index Medicus
Journal Article
Cancer Cell, ISSN 1535-6108, 06/2017, Volume 31, Issue 6, pp. 848 - 848.e1
Journal Article
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 07/2017, Volume 18, Issue 7, p. 1414
Carcinogenesis cannot be explained only by genetic alterations, but also involves epigenetic processes. Modification of histones by acetylation plays a key... 
Histone deacetylase inhibitors | Anti-angiogenic effect | Cell cycle arrest | Drug combinations | Histone deacetylases | Autophagy | Apoptosis | Cancer | HDAC INHIBITORS | autophagy | SUBEROYLANILIDE HYDROXAMIC ACID | HUMAN LEUKEMIA-CELLS | NITRIC-OXIDE SYNTHASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMOR-SUPPRESSOR GENES | apoptosis | VALPROIC ACID | cell cycle arrest | anti-angiogenic effect | CHEMISTRY, MULTIDISCIPLINARY | drug combinations | CELL LUNG-CANCER | EPITHELIAL-MESENCHYMAL TRANSITION | PHASE-II TRIAL | LONG NONCODING RNA | histone deacetylases | cancer | histone deacetylase inhibitors | Immunomodulation - drug effects | Apoptosis - drug effects | Humans | Angiogenesis Inhibitors - pharmacology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Autophagy - drug effects | Acetylation - drug effects | Animals | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Cycle Checkpoints - drug effects | Angiogenesis Inhibitors - therapeutic use | Histone Deacetylase Inhibitors - pharmacology | Antineoplastic Agents - pharmacology | Epigenesis, Genetic - drug effects | Histone Deacetylase Inhibitors - therapeutic use | Gene Expression Regulation, Neoplastic - drug effects | Drug Evaluation, Preclinical
Journal Article